
Net earnings attributable to Procter & Gamble decreased 4% to $3.9 billion while EPS dropped 2% to $1.57 compared to last year. Core EPS fell 2% to $1.57.
For FY2023, P&G expects all-in sales to be down 3% to 1% versus the prior year while organic sales are expected to grow 3-5%.
Prior performance
